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Introduction
Stroke is responsible for the death of nearly 130,000 Americans annually. Of the
estimated 800,000 strokes that occur in the United States each year, approximately 87% are
ischemic. Ischemic stroke occurs when a blood vessel is blocked in the brain, hindering the
vessel’s ability to provide oxygen and nutrients to brain tissue. Patients who survive ischemic
stroke experience delayed neuronal death (DND), which has been linked to an increase in the
presence of Ca2+-­permeable AMPA receptors (AMPARs) at the cell surface1.
AMPARs are tetramers composed of GluA1-­4 subunits and can be either homomeric or
heteromeric2. A majority of AMPARs are impermeable to calcium due to a post-­transcriptional
modification in the channel pore of the GluA2 AMPAR subunit3. GluA2 initially undergoes
internalization and subsequently is trafficked to lysosomal degradation following OGD/R insult4.
The subsequent increase in the expression of GluA2-­lacking, Ca2+-­permeable AMPARs results
in excitotoxicity, eventually resulting in DND5.
Following OGD/R and the subsequent influx of Ca2+, superoxide generators are
activated6. We hypothesize that the internalization of GluA2-­containing AMPARs
following oxygen-­glucose deprivation/reperfusion (OGD/R), an in vitro model for
ischemic stroke, is mediated through an oxidative stress signaling cascade.
SNB-­19, a human astroglioma cell line, and SH-­SY5Y, a human neuroblastoma cell line,
were transiently transfected with fluorescently tagged GluA1 and GluA2, as well as different
Rab proteins. Rab 5 is localized to early endosomes. Rab 7 is localized to late endosomes
destined for lysosomal degradation. Rab11 is localized to recycling endosomes that undergo
exocytosis. We pretreated the transfected cells with MnTMPyP, a superoxide scavenger, and
observed the endocytic trafficking of GluA1 and GluA2 AMPAR subunits following OGD/R .
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• Pre-­treatment with MnTMPyP, a superoxide scavenger, ameliorates the ischemic/reperfusion
injury-­induced internalization of the GluA1 and GluA2 AMPAR subunits.
• The GluA1 AMPAR subunit colocalizes with Rab11, a marker for recycling endosomes
destined to undergo exocytosis, under both normoxic and ischemic conditions;; indicating that
there is likely an intracellular pool of GluA1 AMPARs. GluA2 does not colocalize with Rab11
under normoxic nor ischemic/reperfusion conditions.
• Following ischemic/reperfusion insult, both the GluA1 and GluA2 AMPAR subunits colocalize
with Rab7, a marker for late endosomes that eventually undergo lysosomal degradation.
Treatment with MnTMPyP before ischemic insult ameliorated the degradation of both the
GluA1 and GluA2 AMPAR subunits.
• These data indicate that the excitotoxic internalization and degradation of AMPAR subunits
following ischemic/reperfusion injury is oxidative stress mediated.
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Cell Culture
SNB-­19 cells were generously gifted from Dr. Richard Bridges. SNB-­19 cells were maintained
in DMEM/F12, supplemented with fetal bovine serum and penicillin/streptomycin. Once cells
reached 75% confluency, they were passaged.
Transfection
SNB-­19 cells were transfected with GluA1-­tdTomato/GFP or GluA2-­tdTomato/GFP, generously
gifted from Dr. Richard Huganir, and either Rab 5-­cerulean, Rab7-­RFP, and Rab11-­RFP. Cells
were transfected using Lipofectamine 2000 in Opti-­mem media for 4 hours before the media
was replaced with phenol red-­free DMEM media supplemented with fetal bovine serum and
penicillin/streptomycin. Experiments were performed 48 hours after transfection.
AMPA Stimulation
Transfected SNB-­19 cells (75,000 cells/well) were exposed to 100µM AMPA, 100µM
cyclothiazide, and 100µM MnTMPyP for 3 minutes before being removed and replaced with
phenol-­red free DMEM media and fixed with 4% paraformaldehyde at time points: 5 and 10
minutes. Cells were then washed 2x with PBS, and mounted on slides.
OGD/R
Transfected SNB-­19 cells were exposed to deoxygenated artificial cerebrospinal fluid without
glucose in a hypoxic chamber for 20 minutes. Media was then replaced with artificial
cerebrospinal fluid containing glucose and cells were reperfused at 0, 5, 15, or 30 minute time
points. Experiments were also done in the presence of 100µM MnTMPyP, a superoxide
dismutase mimetic. Cells were fixed in 4% paraformaldehyde for 20 mins, washed 2x with PBS,
and mounted on slides (75,000 cells/well). Normoxic controls were time-­matched with the
longest reperfusion time point.
Data Analysis/Scientific Rigor
Cells were imaged via confocal microscopy (Fluoview Olympus) and colocalization coefficients
were obtained using FIJI software (NIH) . One-­way ANOVA with Tukey post Hoc test were
conducted using GraphPad Prism software to determine significance. All imaging and analysis
was performed blindly.
Stroke  is  the  fifth  leading  cause  of  death  annually  in  the  United  States,  resulting  in  nearly  
130,000  deaths  per  year.  Ischemic  stroke  is  the  most  common  form  of  stroke  and  occurs  when  a  
blood  vessel  supplying  the  brain  is  occluded.  This  blockage  leads  to  deprivation  of  oxygen  and  
nutrients  to  brain  tissue,  resulting  in  delayed  neuronal  death  (DND).  In  the  hippocampus,  a  
region  susceptible  to  DND,  there  is  high  expression  of  glutamatergic  AMPA  receptors  
(AMPARs).  The  majority  of  AMPARs  expressed  in  the  hippocampus  contain  an  edited  form  of  
the  GluA2  (Q607R)  subunit,  resulting  in  Ca2+-­impermeable  AMPARs.  Following  ischemic/stroke  
injury,  the  GluA2  AMPAR  subunit  is  internalized  and  subsequently  degraded,  resulting  in  GluA2-­
lacking  AMPARs  that  are  Ca2+-­permeable.  Previous  studies  have  indicated  an  increased  
production  of  superoxide  radicals  following  ischemic  stroke  injury,  which  have  a  significant  role  
in  mediating  oxidative  stress-­induced  neuronal  injury.  Based  upon  previous  studies,  it  is  
suggested  that  an  oxidative  stress  signaling  cascade  is  responsible  for  initiating  events  leading  
to  the  internalization  and  degradation  of  the  GluA2  AMPAR  subunit  following  oxygen-­glucose  
deprivation/reperfusion  (OGD/R),  an  in  vitro model  for  ischemic  stroke.  
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